Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice

作者：Xu Renfan; Tao Anyu; Zhang Shasha; Zhang Muxun^*

来源：Acta Biochimica et Biophysica Sinica, 2013, 45(9): 726-733.

DOI：10.1093/abbs/gmt065

• non-alcoholic fatty liver disease
• IL-17mAb
• NF-kappa B

Non-alcoholic fatty liver disease (NAFLD) is hepatic manifestation of a metabolic syndrome and includes a spectrum of hepatic steatosis, steatohepatitis, and fibrosis. Interleukin-17 (IL-17) has been reported to play a critical role in inflammatory progression of some liver diseases. The present study was designed to investigate the role of IL-17 on high fat diet-induced NAFLD in C57BL/6 mice. IL-17 blockade with anti-IL-17mAb significantly improved liver function, attenuated hepatic lipid accumulation, suppressed Kuffer cells activation, and decreased proinflammatory cytokines levels, which were associated with inhibition of NF-kappa B signaling cascades activation. Our data suggested that IL-17 was related to disease progression in NAFLD mouse model and blocking IL-17 may be a promising novel therapeutic approach for patients with NAFLD.

• 出版日期2013-9
• 单位华中科技大学